Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

R.A. Nout; V.T. Smit; H. Putter; I.M. Jürgenliemk-Schulz; J.J. Jobsen; L.C. Lutgens; E.M. van der Steen-Banasik; J.W. Mens; A. Slot; M.C. Kroese; B.N. van Bunningen; A.C. Ansink; W.L. van Putten; C.L. Creutzberg

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

Translated title of the contribution: Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

R.A. Nout
, V.T. Smit
, H. Putter
, I.M. Jürgenliemk-Schulz
, J.J. Jobsen
, L.C. Lutgens
, E.M. van der Steen-Banasik
, J.W. Mens
, A. Slot
, M.C. Kroese
, B.N. van Bunningen
, A.C. Ansink
, W.L. van Putten
, C.L. Creutzberg

Medical Physics Group

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial
Original language	Undefined/Unknown
Pages (from-to)	816-823
Number of pages	8
Journal	The Lancet
Volume	375
Issue number	9717
Publication status	Published - 2010

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/20206777

Cite this

Nout, R. A., Smit, V. T., Putter, H., Jürgenliemk-Schulz, I. M., Jobsen, J. J., Lutgens, L. C., van der Steen-Banasik, E. M., Mens, J. W., Slot, A., Kroese, M. C., van Bunningen, B. N., Ansink, A. C., van Putten, W. L., & Creutzberg, C. L. (2010). Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. The Lancet, 375(9717), 816-823. http://www.ncbi.nlm.nih.gov/pubmed/20206777

@article{d9db26dac9ea4c9d82ee18a5afd1fcb8,

title = "Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial",

author = "R.A. Nout and V.T. Smit and H. Putter and I.M. J{\"u}rgenliemk-Schulz and J.J. Jobsen and L.C. Lutgens and \{van der Steen-Banasik\}, E.M. and J.W. Mens and A. Slot and M.C. Kroese and \{van Bunningen\}, B.N. and A.C. Ansink and \{van Putten\}, W.L. and C.L. Creutzberg",

year = "2010",

language = "Undefined/Unknown",

volume = "375",

pages = "816--823",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9717",

}

Nout, RA, Smit, VT, Putter, H, Jürgenliemk-Schulz, IM, Jobsen, JJ, Lutgens, LC, van der Steen-Banasik, EM, Mens, JW, Slot, A, Kroese, MC, van Bunningen, BN, Ansink, AC, van Putten, WL & Creutzberg, CL 2010, 'Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial', The Lancet, vol. 375, no. 9717, pp. 816-823. <http://www.ncbi.nlm.nih.gov/pubmed/20206777>

TY - JOUR

T1 - Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

AU - Nout, R.A.

AU - Smit, V.T.

AU - Putter, H.

AU - Jürgenliemk-Schulz, I.M.

AU - Jobsen, J.J.

AU - Lutgens, L.C.

AU - van der Steen-Banasik, E.M.

AU - Mens, J.W.

AU - Slot, A.

AU - Kroese, M.C.

AU - van Bunningen, B.N.

AU - Ansink, A.C.

AU - van Putten, W.L.

AU - Creutzberg, C.L.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0140-6736

VL - 375

SP - 816

EP - 823

JO - The Lancet

JF - The Lancet

IS - 9717

ER -